Epidemiology of non-oncological high-impact chronic pain in Ecuadorian adults in 2022.
Debora B MartineauManuel E BaldeónDaniela SuárezMario PazCinthia ValarezoEnrique LoorMarixa GuerreroPublished in: Pain management (2024)
Background: There are limited data on non-oncological high-impact chronic pain (HICP) in Ecuador; we report the epidemiological characteristics of HICP. Materials & methods: In this cross-sectional study, we included a random sample of adult individuals who had cell phones. Results & conclusion: The weighted prevalence of HICP was 9.0%: 12.3% for women and 5.6% for men (p = 0.001). HICP was more frequently localized in the lower back and affected the economically active population. Nonsteroidal anti-inflammatory drugs were more commonly used; however, 61% of patients indicated that the effectiveness of their management was low. Overall, HICP had a negative impact on daily life activities. The effectiveness of the current treatment was low and should include an integrated approach.
Keyphrases
- chronic pain
- randomized controlled trial
- systematic review
- anti inflammatory drugs
- risk factors
- ejection fraction
- newly diagnosed
- pain management
- type diabetes
- magnetic resonance
- single cell
- prostate cancer
- rectal cancer
- metabolic syndrome
- cell therapy
- electronic health record
- bone marrow
- mesenchymal stem cells
- middle aged
- deep learning
- artificial intelligence
- peritoneal dialysis
- network analysis
- data analysis
- cervical cancer screening